Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
CRB1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Invitae Macular Dystrophy Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 66 | 36 |
|
PreventionGenetics, part of Exact Sciences United States | 285 | 137 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Inherited Retinal Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 486 | 293 |
|
Invitae Comprehensive Carrier Screen Labcorp Genetics (formerly Invitae) LabCorp United States | 886 | 547 |
|
Molecular Vision Laboratory United States | 342 | 268 |
|
Stargardt Disease (STGD) and Macular Dystrophies Panel PreventionGenetics, part of Exact Sciences United States | 35 | 28 |
|
PreventionGenetics, part of Exact Sciences United States | 91 | 82 |
|
Autosomal Dominant Retinitis Pigmentosa (RP) Panel PreventionGenetics, part of Exact Sciences United States | 32 | 30 |
|
Autosomal Recessive Retinitis Pigmentosa (RP) Panel PreventionGenetics, part of Exact Sciences United States | 62 | 60 |
|
Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center Netherlands | 3 | 1 |
|
Leber Congential Amaurosis Panel (MitomeNGS) Baylor Genetics United States | 32 | 19 |
|
Baylor Genetics United States | 3 | 1 |
|
CRB1 Deletion/Duplication Analysis Baylor Genetics United States | 3 | 1 |
|
CRB1 Comprehensive - Sequence & Deletion/Duplication Analysis Baylor Genetics United States | 3 | 1 |
|
CRB1 Sequence Analysis (Prenatal Diagnosis) Baylor Genetics United States | 3 | 1 |
|
Leber Congenital Amaurosis and Retinitis Pigmentosa via the CRB1 Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.